NL-OMON23518已完成不适用
A placebo controlled study on the effect of oxandrolone in combination with authentic biosynthetic human growth hormone and low-dose oestrogens on growth and metabolic parameters in girls with Turner's syndrome.
Pfizer (New York), previously Pharmacia; and Lilly (Indianapolis, USA)0 个研究点目标入组 135 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 135
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Turner syndrome, confirmed by chromosomal analysis. 3 age ranges: 2.00-7.99 yrs, 8-11.99 yrs, 12.00-15.99 yrs.
排除标准
- •1. Any other disorder that may affect growth;
- •2. Hydrocephalus;
- •3. Other experimental drug study;
研究者
相似试验
已完成
不适用
A placebo controlled study on the effect of oxandrolone, growth hormone and low-dose estrogens on growth, psychological parameters, and characteristics of the voicein girls with Turner's syndrome.Girls with Turner syndrome.NL-OMON29682ederlandse Groeistichting (Dutch Growth Foundation)133
已完成
不适用
A placebo controlled study on the effect of oxandrolone in combination with authentic biosynthetic human growth hormone (GH) and low-dose oestrogens on growth and metabolic parameters in girls with Turner's syndromeTurner syndromeISRCTN54336338Dutch Growth Foundation (Netherlands)135
已完成
3 期
A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated PainParkinson's Disease With Severe PainNCT01439100Mundipharma Research GmbH & Co KG172
撤回
3 期
Placebo Versus Oxandrolone Supplementation in TraumaTrauma InjuryNCT05516849Sunnybrook Health Sciences Centre
已完成
3 期
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back PainLow Back PainNCT01358526Purdue Pharma LP1,095